As of Q4'25, KO's latest reported SG&A Expenses stand at 4.2B USD, while R&D Expenses remain at 0 USD. This marks the highest SG&A Expenses in the observed period, with no allocation to R&D throughout the entire timeframe. From Q1'23 to Q4'25, KO's operating expenses have been entirely driven by SG&A, which shows a generally upward trend with seasonal fluctuations. Notably, SG&A Expenses increased from 3.2B USD in Q1'23 to 4.2B USD in Q4'25, with significant peaks typically occurring in the fourth quarter of each year. The absence of R&D Expenses indicates a consistent expense structure focused solely on SG&A activities over the reported quarters.